Introduction: Cardioplegia is a pharmacological approach essential for the protection of the
heart from ischemia–reperfusion (I–R) injury. Over the years, numerous cardioplegic …

Cardioplegia is an integral and essential method of myocardial protection for patients of all
ages requiring cardiac surgery in which the heart must be stopped. Numerous cardioplegia …

Del Nido cardioplegia is believed to be both clinically and economically efficient. The
interest in this myocardial protection method has been continuously growing. However, the …

The management of congenital heart disease has changed dramatically over the last 15
years and continues to evolve at a rapid pace. More than ever before contemporary practice …

Abstract Objectives The del Nido cardioplegia solution has been used extensively in
congenital heart surgery for more than 20 years and more recently for adults. This …

Abstract Objective Del Nido (DN) cardioplegia solution provides a depolarized hyperkalemic
arrest lasting up to 60 minutes, and the addition of lidocaine may limit intracellular calcium …

Cardiac arrest by cardioplegia provides a reproducible and safe method to induce and
maintain electromechanical cardiac quiescence. Techniques of intraoperative myocardial …

Abstract Background and Aims The immediate postischemic period is marked by elevated
intracellular calcium levels, which can lead to irreversible myocyte injury. Del Nido …

Objectives To compare the cardioprotective efficacy of a solution that requires only a single
infusion at the start of the ischemic duration versus a solution that requires multiple …

Background: The single dose cardioplegia technique for myocardial protection during
congenital heart surgery is a viable alternative to multidose protocols. Methods: Thirty-four …